Organization · Community
USAIC
The USA-India Chamber of Commerce (USAIC) fosters collaboration between the U.S. and India in the BioPharma and healthcare sectors, driving innovation and regulatory reform through dialogue and partnerships among industry professionals.
Overview
What USAIC does
What USAIC is
The USA-India Chamber of Commerce (USAIC) fosters collaboration between the U.S. and India in the BioPharma and healthcare sectors, driving innovation and regulatory reform through dialogue and partnerships among industry professionals.
How it participates in the startup ecosystem
The current public profile supports community and event host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Community
- Structured capabilities
- Community · Event host
- Last reviewed
- April 1, 2026
Official channels
Find USAIC elsewhere
Open the official website or a supported primary organization account.
Capability profile
USAIC as a community
Community overview
The USA-India Chamber of Commerce (USAIC) is an organization focused on fostering collaboration between the United States and India in the BioPharma and healthcare sectors. It was founded to create a platform for dialogue and partnership among industry professionals, policymakers, and academics. The organization is based in the United States and aims to drive innovation and regulatory reform in the life sciences and healthcare industries.
Community focus
USAIC invests in and provides services related to BioPharma and healthcare innovation. Its focus includes catalyzing partnerships, promoting new ideas, and facilitating regulatory reform. The organization engages with a diverse mix of senior industry professionals and aims to enhance the global dialogue on healthcare innovation.
Membership
- Pricing models
- free
Format and cadence
- Modality
- in-person
- Commitment
- light
Availability
- Membership state
- Accepting
- Next recorded event
- April 30, 2026
Audience and fit
- Audience
- Founders · Investors · Researchers
- Benefits
- network-access and mentorship
- Program types
- community and other
- Selection criteria
- open
- Regions
- IndiaUnited States
Community activity
- Annual events
- 1
Events and activity
USAIC hosts several events, including the BioPharma & Healthcare Summit, an annual event that features panels and discussions on various topics in the BioPharma sector, and the Delhi BioPharma Strategy Session, aimed at catalyzing innovation in the BioPharma sector in India.
Notable members
Notable individuals associated with USAIC include Dr. Stelios Papadopoulos (Chairman of the Board, Exelixis), Dr. Andrew Plump (President of R&D, Takeda), Christopher Viehbacher (President & CEO, Biogen), Daphne Zohar (Founder & CEO, Seaport Therapeutics), and Dr. Elias Zerhouni (Vice Chairman, OPKO Health).
Capability profile
USAIC as an event host
Event focus
USAIC invests in and provides services related to BioPharma and healthcare innovation. Its focus includes catalyzing partnerships, promoting new ideas, and facilitating regulatory reform. The organization engages with a diverse mix of senior industry professionals and aims to enhance the global dialogue on healthcare innovation.
Format narrative
USAIC organizes the BioPharma & Healthcare Summit, an annual event that gathers industry leaders, academicians, and investors to discuss emergent science and explore new opportunities in the BioPharma sector.
Participant value
USAIC provides a platform for dialogue and partnership among industry professionals, policymakers, and academics, driving innovation and regulatory reform in the life sciences and healthcare industries.
Format and cadence
- Event types
- summit
- Recurrence
- annual
- Modality
- in-person
- Startups can present
- No
Availability
- Registration state
- Not currently accepting
- Next recorded event
- April 30, 2026
- Next event location
- The Newbury Boston Hotel, Boston, Massachusetts
Audience and fit
- Audience
- Founders · Investors · Corporate Innovators
- Regions
- IndiaUnited States
Speakers and past editions
Speakers
Notable speakers include Dr. Stelios Papadopoulos (Chairman of the Board, Exelixis), Dr. Andrew Plump (President of R&D, Takeda), Christopher Viehbacher (President & CEO, Biogen), Daphne Zohar (Founder & CEO, Seaport Therapeutics), and Dr. Elias Zerhouni (Vice Chairman, OPKO Health).
Past editions
The BioPharma & Healthcare Summit has featured panels and discussions on various topics in the BioPharma sector, bringing together industry leaders and innovators.
Common questions
What to know about USAIC
Upseed classifies USAIC under the Community organization type. Its current public profile includes community and event host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 1, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.